CIPO trademark

NeoMab-CLC

RegisteredCIPOFigurative markClass 31Class 42

"NeoMab-CLC" is a figurative mark owned by GemPharmatech Co., Ltd., filed at the CIPO on May 22, 2024. It is registered and covers classes 31 and 42.

View GemPharmatech Co., Ltd. portfolio Get this data via the API

Data current as of July 30, 2025Official CIPO record

As filed with the CIPO

Status: Registered; Since July 25, 2025
Filed: May 22, 2024
Registered: July 25, 2025
Expires: July 25, 2035
Application no.: 2328451
Registration no.: TMA1335417
Office: CIPO; Canadian Intellectual Property Office
Mark type: Figurative mark; 2 classes

Ownership

Who owns NeoMab-CLC

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GemPharmatech Co., Ltd.

China

31 trademarks in the portfolioView company

Representative

Neomark Ltd.

Goods and services

What the mark covers

The products and services NeoMab-CLC is filed for, grouped by Nice class.

31Class 31 · Natural Agricultural Products
Bran mash for animal consumption; edible chews for animals; foodstuffs for livestock; fresh fruit; fresh garden herbs; litter for animals; live laboratory animals; mushroom spawn for propagation; rice meal for forage; unprocessed algae for human or animal consumption
42Class 42 · Computer and Scientific Services
Biological therapeutic research services; biomedical research services; chemical laboratories; chemical research; culturing of cells for scientific research purposes; medical research; providing scientific research information in the fields of pharmaceuticals; research and development of new products for others; research in the fields of biologic therapeutic preparations; scientific research in the field of genetics; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry

History

What has happened so far

Steps recorded by the CIPO, newest first.

July 25, 2025Registered
July 25, 2025Registration Pending
May 7, 2025Advertised; Vol.72 Issue 3680
April 14, 2025Approval Notice Sent; APPROVED BY PROGRAM EX200M1
April 14, 2025Approved; APPROVED BY PROGRAM EX200M1
April 4, 2025Search Recorded
May 22, 2024Formalized
May 22, 2024Created
May 22, 2024Filed

FAQ

About NeoMab-CLC

Who owns the trademark "NeoMab-CLC"?

The CIPO trademark "NeoMab-CLC" (application 2328451) is owned by GemPharmatech Co., Ltd.

What is the status of "NeoMab-CLC"?

Its status at the CIPO is: registered.

When was "NeoMab-CLC" registered?

It was registered on July 25, 2025 and is due to expire on July 25, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NeoMab-CLC and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019deb46-6a3d-74e9-9b63-d93e24bdefb6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019deb46-6a3d-74e9-9b63-d93e24bdefb6",
  "object": "trademark",
  "mark_text": "NeoMab-CLC",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2328451",
  "filing_date": "2024-05-22",
  "nice_classes": [
    31,
    42
  ],
  "owners": [
    {
      "name": "GemPharmatech Co., Ltd.",
      "entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
    }
  ]
}